|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
ReCyte Therapeutics, Inc.
| | | Phone: | (510) 521-3390 | Year Established: | 2011 | Ticker: | BTX | Exchange: | NYSE | Main Contact: | Michael West, Ph.D., CEO | | Other Contacts: | David Larocca, Ph.D., VP, R&D
| |
| Company Description | ReCyte Therapeutics, formerly Embryome Sciences, and a a subsidiary of BioTime, is a regenerative medicine company focused on repair of vascular disorders, including both age-related diseases and injuries. | |
|
|
|
|
|